Madrigal Pharmaceuticals

As we wrap-up 2024, we're incredibly proud of our achievements this year. From launching the first FDA approved therapy in #NASH / #MASH to working closely with the MASH community, we've enjoyed every moment. We look forward to the opportunities that lie ahead in 2025 and beyond as we continue to lead the fight against MASH.

Living with #MASH presents challenges that require immense strength and resilience. The courage of those affected inspires us to advance science and innovation. To the patients, caregivers, families, and healthcare professionals—thank you for your dedication and support to those living with MASH. Together, we’re making strides to take control of #LiverHealth. 

While Michael Small, Executive Director of Sales, was on vacation, his team in the Northeast zone secretly pulled together a donation drive to support Small Miracles Inc., an organization founded by Mike’s daughter Jordyn following her brain tumor diagnosis in 2017. Now a junior at Notre Dame, Jordyn (pictured on the left) and her parents continue to help families by delivering gift bags to Children’s Hospital of Philadelphia and other hospitals that support pediatric oncology patients. The team’s donation was another ‘small miracle’ that makes Madrigal a special place to work, says Mike. #LifeAtMadrigal

Congratulations on your one-year anniversary with Madrigal, Anand Desai. Thank you for listening to your “voice of reason” and deciding to come onboard and build something special. #LifeAtMadrigal https://lnkd.in/e-ukDSGC

A healthy liver is paramount to our overall well-being. Hear from Susan, a #NASH / #MASH patient advocate, on the importance of understanding your diagnosis to help improve health outcomes.

We’re proud to introduce our latest Patient Service Announcement, 'Family Dinner,' where Olivia—based on real-life patient advocate Terri—returns to help her family understand the risks and dangers of liver scarring.

Nearly 100 people attended Madrigal’s #NASH / #MASH Community Voices Listening Session on Thursday, Nov. 14 in San Diego, including 80 patients, caregivers and patient advocacy organization representatives. Personal journeys and a number of topics were discussed, including the real human burden of NASH and the importance of the patient voice in clinical research. Thank you to everyone for your engagement, honesty, and feedback! 

Madrigal is proud to sponsor the Women’s Luncheon at the American Association for the Study of Liver Diseases (AASLD)'s The Liver Meeting® on November 18. The event is dedicated to helping female leaders in hepatology network, tackle challenges, and build a supportive community. #TLM24 

Attending #TLM24? Stop by booth 1239 to interact with these anatomically accurate liver models and feel the various stages of fibrosis in #NASH / #MASH.

Did you know that the American Association for the Study of Liver Diseases (AASLD)’s Diversity, Equity and Inclusion committees are hosting a special social networking meet-up on November 16? Meet other meeting attendees interested in #diversity and #inclusion from 9:45 - 10:45 a.m. in the Sails Pavilion on the 2nd floor of the Convention Center.